Correction: Interim report January – September 2022
Correction: In the press release sent at 08:00 this morning, the interim report was not included. It is now attached. Oslo, Norway, November 1, 2022 – Genetic Analysis AS (“GA” or “the Company”) hereby publishes the interim report for the period January 1 – September 30, 2022. The interim report is available as an attached file to this release and on the Company’s website. Below is a summary of the report.Genetic Analysis CEO Ronny Hermansen comments: “An important milestone ahead is the completion of our research use only (RuO) tool of the IBD prognostic marker, and we are thrilled